BCAX SCHEDULE 13G/A: SEC filing
An institutional investor
Filed with the SEC on · accession 0001897612-26-000635
BCAX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 7, 2026. An institutional investor filed an amended Schedule 13G for Bicara Therapeutics Inc. (BCAX), indicating a change in beneficial ownership position. The stock moved -0.8% by the first close after the filing.
Summary of the filing
An institutional investor filed an amended Schedule 13G for Bicara Therapeutics Inc. (BCAX), indicating a change in beneficial ownership position. The filing does not disclose specific ownership percentages or share counts in the available text.
Key details
How BCAX stock reacted
Close before
$16.56
Oct 6, 2026
First close after
-0.85%
$16.42
5 trading days
+4.71%
$17.34
Since filing
-52.11%
$7.93
✦ Ask GOAX AI about this filing — what it means for BCAX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BCAX?
Click hereFrequently asked questions
What did BCAX file with the SEC on Oct 7, 2026?
BCAX filed a SCHEDULE 13G/A (SEC filing). An institutional investor filed an amended Schedule 13G for Bicara Therapeutics Inc. (BCAX), indicating a change in beneficial ownership position. The filing does not disclose specific ownership percentages or share counts in the available text.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did BCAX stock react to this filing?
BCAX closed at $16.56 before the filing and $16.42 on Oct 7, 2026 (-0.85%). Five trading days later: $17.34 (+4.71%).
Other BCAX SEC filings
- 8-K · SEC filingAug 25, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingAug 11, 2026
- 8-K · Board changeJul 28, 2026
- 144 · Insider sale plannedJul 10, 2026
- 8-K · Board changeJun 10, 2026
- 8-K · Fda approvalMay 21, 2026
- 10-Q · SEC filingMay 11, 2026
- 8-K · SEC filingMay 11, 2026
- DEF 14A · Board changeApr 27, 2026
Get alerts when BCAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days